FACTOR XA INHIBITOR
Clinical trials for FACTOR XA INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new FACTOR XA INHIBITOR trials appear
Sign up with your email to follow new studies for FACTOR XA INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study tracks emergency bleeding reversal drug in 300 patients
Disease control Recruiting nowThis study monitors the safety and effectiveness of Ondexxya, a drug used to reverse the effects of certain blood thinners (apixaban, rivaroxaban, or edoxaban) during life-threatening or uncontrollable bleeding. Researchers will track side effects and how well the drug works in 3…
Matched conditions: FACTOR XA INHIBITOR
Sponsor: AstraZeneca • Aim: Disease control
Last updated May 26, 2026 08:59 UTC
-
New trial could unlock lifesaving stroke treatment for thousands on blood thinners
Disease control Recruiting nowThis study tests whether stroke patients who take FXa inhibitor blood thinners can safely receive a standard clot-busting drug (IVT) without raising their risk of brain bleeding. Current guidelines deny IVT to these patients due to bleeding concerns, but new evidence suggests it …
Matched conditions: FACTOR XA INHIBITOR
Phase: PHASE3 • Sponsor: Guri Hagberg • Aim: Disease control
Last updated May 22, 2026 14:05 UTC